Farcast Biodynamics
PrivateLast Round
Series C
Jul 11, 2018
Total Funding Raised
$80.6M
Company Overview
Farcast Biodynamics operates in Healthcare & Life Sciences and is based in Woburn, Massachusetts. Its latest recorded funding round was a Series C round in July 2018.
Farcast Biodynamics is a biotechnology company that develops a proprietary tumor microenvironment platform to predict cancer treatment responses and accelerate drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Farcast Biodynamics Comparables
Compare Farcast Biodynamics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kiyatec | 86% | |
| Xsphera Biosciences | 86% | |
| Nilogen Oncosystems | 85% |
For institutional investors. Book with your work email.
Farcast Biodynamics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 11, 2018 | ||||
| Series B Extension | Aug 29, 2016 | ||||
| Series B | Oct 25, 2013 | ||||
| Series A | Apr 27, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Farcast Biodynamics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series B Extension |
| Peak XV Partners | Series B Extension |
| Northpond Ventures | Series C |
| Sequoia Capital | Series C |
| Karnataka Information Technology Venture Fund | Series A |
| India Innovation Fund | Series B, Series A |
| Sands Capital | Series C, Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2013
$7M round led by Tata Capital Innovations Fund.
- Apr 27, 2010
$7M round led by Accel.
For institutional investors. Book with your work email.
Farcast Biodynamics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Farcast Biodynamics's valuation, stock price, and market status.
Is Farcast Biodynamics a public or private company?
Farcast Biodynamics is a private company.
What is the current stock price of Farcast Biodynamics?
Farcast Biodynamics is a private company, so its shares have no public market price. Caplight tracks Farcast Biodynamics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Farcast Biodynamics worth (valuation)?
Valuation information for Farcast Biodynamics is not publicly available.
Can I buy Farcast Biodynamics stock?
Farcast Biodynamics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Farcast Biodynamics's last funding round?
Farcast Biodynamics's most recent funding round was Series C on July 11, 2018.
Who are the main investors in Farcast Biodynamics?
Key investors in Farcast Biodynamics include Peak XV Partners, Northpond Ventures, Sands Capital.
Will Farcast Biodynamics IPO soon?
No public IPO plans have been announced for Farcast Biodynamics.
How can I track Farcast Biodynamics secondary market activity?
Caplight tracks bids, offers, and trades in Farcast Biodynamics's shares on secondary markets.